Skip to content
Menu

Maravai LifeSciences Holdings, Inc. MRVI

Full chart Compare
Set alert

Price alert · MRVI

All alert types
7.40 USD -0.14 (-1.86%)

Regular-session close

7.07 -0.33 -4.53%

Pre-market · Nov 17, 4:19 AM ET

7.09 Day range 7.60
2.80 52-week range 9.42
YTD
+127.69%
1 year
+103.30%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Other Operating Income$154.67MIncome Tax Benefit$4.21MGross Profit$33.39MNet Loss$130.77MCost of Revenue$152.35MExpenses$323.05MSelling, General & Admin$171.47MResearch & Development$23.33MInterest Expense$26.99MOther Expenses$101.25MRevenue$185.74MNorth America$112.38MAsia Pacific$41.47MEmea$30.92MLatin And Central America$971.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

MRVI annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
185.74M259.19M288.94M883.00M799.24M
33.99M108.31M140.20M714.04M658.68M
-215.07M-237.62M-34.93M566.42M554.64M
-130.77M-144.85M-119.03M220.21M182.04M
-0.90-1.05-0.901.671.56
MRVI annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
216.89M322.40M574.96M632.14M551.27M
770.58M1.01B1.49B2.28B1.92B
397.87M431.04M697.57M1.38B1.37B
321.91M327.04M556.68M527.44M530.59M
212.38M325.29M416.75M545.22M315.50M
MRVI annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-57.57M7.46M126.22M535.98M368.57M
-31.41M-24.32M-122.31M-267.61M105.66M
-16.50M-235.71M-61.09M-187.50M-159.05M
-12.41M-22.52M-52.69M-29.26M-14.30M
-105.51M-252.56M-57.18M80.87M315.09M